RAMM Pharma Corp. Provides Update on Canapar
Not for Dissemination in the US or through US Newswire Services TORONTO, Jan. 21, 2025 (GLOBE NEWSWIRE) — RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: RAMM), is exploring strategic options for the potential sale o…
Author of the article:
Article content
Not for Dissemination in the US or through US Newswire Services
TORONTO, Jan. 21, 2025 (GLOBE NEWSWIRE) RAMM Pharma Corp. (including its wholly owned subsidi…